Overcoming barriers to hepatitis C elimination

Manuel Mendizabal^{1

2}, Cristina Alonso^{1

2}, Marcelo O Silva^{1

2}

Affiliations

¹ Hepatology and Liver Transplant Unit, Hospital Universitario Austral, Pilar, Argentina.
² Latin American Liver Research Educational and Awareness Network (LALREAN), Pilar, Argentina.

Manuel Mendizabal et al. Frontline Gastroenterol. 2019 Jul.

. 2019 Jul;10(3):207-209.

doi: 10.1136/flgastro-2018-101114. Epub 2019 Feb 1.

Manuel Mendizabal^{1

2}, Cristina Alonso^{1

2}, Marcelo O Silva^{1

2}

¹ Hepatology and Liver Transplant Unit, Hospital Universitario Austral, Pilar, Argentina.
² Latin American Liver Research Educational and Awareness Network (LALREAN), Pilar, Argentina.

No abstract available

Keywords: antiviral therapy; hepatitis C.

Conflict of interest statement

Competing interests: None declared.

1. World Health Organization. Global Hepatitis report. 2017. www.who.int http://www.who.int/publications/global-hepatitis-report2017/en/ (Accessed 11 Dec 2018).
1. Yehia BR, Schranz AJ, Umscheid CA, et al. . The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis. PLoS One 2014;9:e101554 10.1371/journal.pone.0101554 - DOI - PMC - PubMed
1. Arora S, Thornton K, Bradford A. Access to care: Management of hepatitis C viral infection in remote locations. Clin Liver Dis 2012;1:87–90. 10.1002/cld.46 - DOI - PMC - PubMed
1. Ford N, Singh K, Cooke GS, et al. . Expanding access to treatment for hepatitis C in resource-limited settings: lessons from HIV/AIDS. Clin Infect Dis 2012;54:1465–72. 10.1093/cid/cis227 - DOI - PubMed
1. Johannessen A. Where we are with point-of-care testing. J Viral Hepat 2015;22:362–5. 10.1111/jvh.12385 - DOI - PMC - PubMed